Description
HAI is currently under investigation for its potential role in the treatment of colorectal cancer, but it has not been approved by regulatory agencies and clinical data on efficacy are limited; its use would be experimental and context-dependent.
Mechanism of Action
HAI is an investigational agent and its mechanism of action in colorectal cancer (CRC) has not been fully elucidated; it may involve modulation of immune response or direct anti-tumor effects.
Side Effects
Adverse events are not well-documented for HAI in colorectal cancer patients; potential side effects may include immune-related adverse reactions
Hematological toxicity
And gastrointestinal symptoms;
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT02102789
Phase 3
Unknown
A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis
China